|

Effect of Diosmin and Hesperidin in Treatment of Patients With Rheumatoid Arthritis

RECRUITINGPhase 3Sponsored by Alexandria University
Actively Recruiting
PhasePhase 3
SponsorAlexandria University
Started2023-07-18
Est. completion2025-09
Eligibility
Age19 Years – 65 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT05756179

Summary

Evaluating the effect of the flavonoids combination (diosmin and hesperidin) as adjuvant therapy on patients with rheumatoid arthritis

Eligibility

Age: 19 Years – 65 YearsHealthy volunteers accepted
Inclusion Criteria:

* Patients with mild to moderate disease activity.
* Patient age must be more than 18 years.

Exclusion Criteria:

* Pregnant and lactating females.
* Patients with liver, renal impairment or any other inflammatory diseases.
* Patients on TNF-α (tumor necrosis factor- α) or IL-1β (interleukin-1β) antagonists.

Conditions2

ArthritisRheumatoid Arthritis

Browse More Trials

Arthritis trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.